Source: Annual Congress 2005 - Pulmonary fibrosis and pleural disease



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gill, K. Janardhan, T. Duke, B. Singh (Saskatoon, Canada). Recruitment and functions of pulmonary intravascular macrophages (PIMs) in biliary cirrhosis. Eur Respir J 2005; 26: Suppl. 49, 3560

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs) Source: Eur Respir J 2001; 18: Suppl. 33, 79s Year: 2001 Resident pulmonary intravascular macrophages (PIMs) are pro-inflammatory while recruited PIMs are anti-inflammatory Source: Eur Respir J 2002; 20: Suppl. 38, 481s Year: 2002 Evaluation of neutrophils phagocytosis and killing in pulmonary cystic fibrosis patients Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Pulmonary intravascular macrophages (PIMs) are recruited following exposure to swine barn air and enhance susceptibility to acute lung inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 347s Year: 2003 Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 A comparison of 99mTc-DTPA clearance and translocation of nano particles in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Evaluation of pulmonary function and functional capacity in patients with liver cirrhosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Study of the system of hemostasis in patients with chronic forms of pulmonary sarcoidosis (PS) with impairments of regional pulmonary blood circulation Source: Eur Respir J 2006; 28: Suppl. 50, 537s Year: 2006 Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001 Lung involvement in primary biliary cholangitis (PBC) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT) Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP) Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Mechanism of bronchoalveolar duct junction (BADJ) remodeling in idiopathic pulmonary fibrosis (IPF) as base for new pathogenetic therapy Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008